Similar articles

• Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition.

  Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Van Belle E, et al. Circulation. 1997 Jan 21;95(2):438-48. doi: 10.1161/01.cir.95.2.438. Circulation. 1997. PMID: 9008462
• Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening.

  Van Belle E, Tio FO, Chen D, Maillard L, Chen D, Kearney M, Isner JM. Van Belle E, et al. J Am Coll Cardiol. 1997 May;29(6):1371-9. doi: 10.1016/s0735-1097(97)00049-1. J Am Coll Cardiol. 1997. PMID: 9137238
• Endothelial recovery: the next target in restenosis prevention.

  Losordo DW, Isner JM, Diaz-Sandoval LJ. Losordo DW, et al. Circulation. 2003 Jun 3;107(21):2635-7. doi: 10.1161/01.CIR.0000071083.31270.C3. Circulation. 2003. PMID: 12782613 No abstract available.
• [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)].

  Banga JD. Banga JD. Ned Tijdschr Geneeskd. 2000 Jan 15;144(3):113-6. Ned Tijdschr Geneeskd. 2000. PMID: 10674116 Review. Dutch.
• Therapeutic angiogenesis: time for the next phase.

  Pantely GA, Porter JM. Pantely GA, et al. J Am Coll Cardiol. 2000 Oct;36(4):1245-7. doi: 10.1016/s0735-1097(00)00885-8. J Am Coll Cardiol. 2000. PMID: 11028478 Review. No abstract available.